Caxton Associates (New York)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $524K | Sell |
|
|||||
|
2024
Q3 | $1.48M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $889K | Hold |
|
|||||
|
2023
Q4 | $984K | Hold |
|
|||||
|
2023
Q3 | $910K | Buy |
|
|||||
|
2023
Q2 | $671K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $66M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $481K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $209K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $995K | Buy |
|
|||||
|
2014
Q3 | – | Hold |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $3.54M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $15.7M | Buy |
|
|||||
|
2013
Q2 | $6.41M | Buy |
|